Harrow, Inc.

Contributing Author

Recent Articles by Harrow, Inc.

7 hours	Harrow Announces Q4 and Full-Year 2025 Financial Results and 2026 Financial Guidance HROW GlobeNewswire
Feb-18	Harrow To Report Fourth Quarter and Year-End 2025 Financial Results After Market Close on March 2, 2026 HROW GlobeNewswire
Feb-17	Harrow Announces Cash-Pay Direct-to-Prescriber PharmaPack Kits HROW +5.98% GlobeNewswire
Feb-02	Harrow Reaffirms 2025 Full-Year Revenue Guidance of $270-$280 Million, Marking Another Year of Strong Growth HROW +9.67% GlobeNewswire
Nov-24	Harrow to Present at Two Investor Conferences in December HROW GlobeNewswire
Nov-18	Harrow Announces Closing of Acquisition of Melt Pharmaceuticals HROW GlobeNewswire
Nov-10	Harrow Announces Third Quarter 2025 Financial Results HROW +13.47% HROW GlobeNewswire
Oct-27	Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025 HROW GlobeNewswire
Oct-06	ImprimisRx Announces Leadership Changes HROW -7.20% GlobeNewswire
Sep-26	Harrow to Acquire Melt Pharmaceuticals HROW GlobeNewswire
Sep-25	Harrow Launches Harrow Access for All (HAFA) HROW GlobeNewswire
Sep-15	Harrow Announces Agenda and Speakers for Investor & Analyst Day HROW +8.63% GlobeNewswire
Sep-08	Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030 HROW +7.52% GlobeNewswire
Sep-08	Harrow Announces Offering of $250.0 Million Senior Unsecured Notes Due 2030 HROW +7.52% GlobeNewswire
Aug-11	Harrow Announces Second-Quarter 2025 Financial Results HROW GlobeNewswire
Aug-06	Harrow to Present at H.C. Wainwright 5th Annual Ophthalmology Conference HROW GlobeNewswire
Jul-29	Harrow To Report Second Quarter 2025 Financial Results After Market Close on August 11, 2025 HROW GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved.